首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Experimental hematology & oncology

缩写:EXP HEMATOL ONCOL

ISSN:N/A

e-ISSN:2162-3619

IF/分区:17.5/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引917条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Silvia R Brandalise,Rosemary Assis,Angelo B A Laranjeira et al. Silvia R Brandalise et al.
Background: Inflammation is a major feature of sickle cell disease (SCD). Low-dose methotrexate (MTX) has long been used in chronic inflammatory diseases. This pilot study examined the MTX effect on acute vaso-occlusive p...
Ying Li,Xin Wang Ying Li
Cullin 4B (CUL4B) is a scaffold of the Cullin4B-Ring E3 ligase complex (CRL4B) that plays an important role in proteolysis and is implicated in tumorigenesis. Aberrant expression of CUL4B has been reported in various types of human diseases...
GuoQing Wei,LiJun Wang,HanJin Yang et al. GuoQing Wei et al.
Background: Multiple myeloma (MM) is a type of hematological malignancy with significant heterogeneity in clinical features and prognosis. Cytogenetic abnormalities are the major factors affecting patient outcomes. Studie...
Eric Bartee,Zihai Li Eric Bartee
Blockade of the programmed cell death protein 1 (PD1) pathway is clinically effective against human cancers. Although multiple types of malignancies have been shown to respond to PD1 agents, only a small percentage of patients typically ben...
Virginie Nägele,Andrea Kratzer,Gerhard Zugmaier et al. Virginie Nägele et al.
Background: Blinatumomab has shown a remission rate of 69% in an exploratory single-arm, phase II dose-escalation study in adult patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL). We evaluat...
Yusuke Isshiki,Hiroaki Tanaka,Yoshio Suzuki et al. Yusuke Isshiki et al.
Background: Thymectomy can effectively cure most thymoma patients; however, patients with advanced thymoma typically require chemotherapy, which is associated with limited efficacy in this context. Here we provide the fir...
Xiaolong Zhang,Yuanyuan Yang,Dongmei Fan et al. Xiaolong Zhang et al.
During the past two decades, a great evolution of bispecific antibodies (BsAbs) for therapeutic applications has been made. BsAbs can bind simultaneously two different antigens or epitopes, which leads to a wide range of applications includ...
Natasha Garg,Constance Stoehr,Yan Shi Zhao et al. Natasha Garg et al.
Background: Esophageal cancer including squamous cell carcinoma (SCC) and adenocarcinoma represents 4% of all cancers in the United States. Patients with esophageal cancer frequently present with locally advanced disease,...
Guoqing Wei,Lijuan Ding,Jiasheng Wang et al. Guoqing Wei et al.
Refractory/relapsed B-cell acute lymphoblastic leukemia remains to be a significant cause of cancer-associated morbidity and mortality for children and adults. Developing novel and effective molecular-targeted approaches is thus a major pri...
Nikki Charlotta Paul Granacher,Zwi N Berneman,Wilfried Schroyens et al. Nikki Charlotta Paul Granacher et al.
Background: Osteolytic bone lesions and hypercalcemia without peripheral blasts B-cell acute lymphoblastic leukemia (B-ALL) is reported in children but rarely seen in adults. ...